ArticleScientific reports2026
The therapeutic potential of zinc-nanoparticles against the cerebellar neurotoxicity induced by bacterial lipopolysaccharides in female rats and their pups.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The potential role of aberrant microglial synaptic pruning in the neurodevelopmental pathogenesis of tourette syndrome.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipopolysaccharide (LPS) is an immunostimulatory endotoxin component of the cell wall of Gram-negative bacteria. LPS correlates with unfavorable developmental consequences, such as preterm birth, fetal demise, teratogenic effects, and intrauterine growth restriction. Zinc is essential for embryogenesis, fetal development, and lactation. This study sought to assess the efficacy of zinc nanoparticles (Zn-NPs) in alleviating cerebellar toxicity caused by LPS in female rats and their offspring. Treatment of LPS-administered female rats with Zn-NPs led to a significant restoration of oxidative stress levels, as indicated by a substantial reduction in malondialdehyde and a marked improvement in superoxide dismutase catalase activity, and Glutathione content in the cerebellar tissues. A significant enhancement was observed in the lipid profiles (total cholesterol, triglycerides, low-density lipoprotein, and high-density lipoprotein) and neurotransmitters (serotonin and dopamine). This was accompanied by significant restoration in the histological and ultrastructural architecture of the cerebellar cortex damaged by LPS. Furthermore, the treatment of LPS-administered mothers with Zn-NPs significantly mitigated the neurodegenerative alterations generated by LPS, as demonstrated by the regulation of synaptophysin, chromogranin, and neuron-specific enolase. Conclusion: Zinc nanoparticles could potentially have a therapeutic role by mitigating cerebellar neurotoxicity caused by bacterial LPS during gestation by reducing oxidative stress and apoptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.